SCHEMBL6017231

SCHEMBL6017231

CCCCC(C(N)=O)(c1ccccc1)C(F)(F)F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.45
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
SCN5A Q14524 3/20 0.41
SCN9A Q15858 3/20 0.41
HTT P42858 1/20 0.41
KCNN4 O15554 5/20 0.39
LMNA P02545 2/20 0.38
CYP2D6 P10635 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
KCNH2 Q12809 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38
EPHX1 P07099 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2699401 0.83 MAPT (0.48) KIF11MAPTKMT2AHTTKCNN4
SCHEMBL20541470 0.78 HTT (0.54) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL3261996 0.77 CYP1A2 (0.42) KIF11MAPTKMT2AHTTLMNA
SCHEMBL2984162 0.77 CHRM3 (0.56) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL6264368 0.77 SCN5A (0.62) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL28150792 0.76 HTT (0.56) KIF11MAPTKMT2ASCN5ASCN9A
Hydrochloric Acid SCHEMBL30448099 0.76 CHRM3 (0.55) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL27351407 0.76 MAPT (0.52) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL2705804 0.74 MAPT (0.46) KIF11MAPTKMT2ASCN5ASCN9A
SCHEMBL31429063 0.73 KIF11 (0.46) KIF11MAPTKMT2AHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660079-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A SEROTONIN MODULATING AGENT FOR THE TREATMENT OF NEOPLASIA Pharmacia Corporation (US) 2006-05-31 EP disclosed
WO-2005018541-A2 COX-2 INHIBITOR AND SEROTONIN MODULATOR FOR TREATING CNS DAMAGE PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed
WO-2005018569-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A SEROTONIN MODULATING AGENT FOR THE TREATMENT OF NEOPLASIA PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed